Draft study says thousands of adverse events are linked to Avandia

An unpublished study conducted by an FDA scientist linked GlaxoSmithKline's diabetes drug Avandia to up to 48,000 heart attacks, strokes and other problems in Medicare patients between 1999 and 2009. The research will be included in the FDA's safety review of Avandia in mid-July, an agency official said.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX